United States CAR-T Cell Therapy Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global CAR-T cell therapy market reached US$ 4.8 billion in 2024 and is expected to reach US$ 20.4 billion by 2033, growing at a CAGR of 16.3% during the forecast period 2025-2033.

Key Development:

United States: Recent CAR-T Cell Therapy Developments

✅ In August 2025, Gilead Sciences' Kite Pharma announced the acquisition of Interius BioTherapeutics for $350 million. This move aims to enhance Kite's CAR-T cell therapy pipeline by integrating Interius' innovative in-vivo delivery platform, which simplifies the treatment process by directly delivering DNA into patients via intravenous infusion.

✅ In July 2025, the CAR T Vision Coalition launched an ambitious initiative to double the number of patients treated with CAR-T cell therapies by 2030. This coalition aims to inspire collective action among stakeholders to expand access to these curative treatments for patients with certain rare, advanced blood cancers.

✅ In May 2025, Cellares, in collaboration with Mitsui Fudosan, began construction of Japan's first next-generation commercial production site for CAR-T cell therapies in Kashiwa City. This facility is expected to scale up manufacturing capabilities, improving patient access to these advanced treatments.

Japan: Recent CAR-T Cell Therapy Developments

✅ In September 2025, Minaris Advanced Therapies launched as a global partner dedicated to cell therapy development, manufacturing, and testing, following the merger of Minaris Regenerative Medicine and WuXi Advanced Therapies operations in the U.S. and U.K. This strategic move aims to strengthen Japan's position in the global cell therapy landscape.

✅ In May 2025, Cellares, in collaboration with Mitsui Fudosan, began construction of Japan's first next-generation commercial production site for CAR-T cell therapies in Kashiwa City. This facility is expected to scale up manufacturing capabilities, improving patient access to these advanced treatments.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/car-t-cell-therapy-market?sb

CAR-T Cell Therapy is an advanced immunotherapy that modifies a patient's T-cells to express chimeric antigen receptors (CARs) targeting specific cancer cells. It is primarily used to treat blood cancers like leukemia and lymphoma, offering personalized, highly effective treatment by enabling the immune system to recognize and destroy malignant cells.

Recent Mergers and Acquisitions:

United States: Recent CAR-T Cell Therapy M&A

✅ In June 2025, AbbVie acquired Capstan Therapeutics for $2.1 billion, enhancing its cell and gene therapy capabilities via Capstan's in vivo CAR-T platform and RNA delivery technology.

✅ In March 2025, Bristol Myers Squibb acquired 2seventy bio for $286 million, gaining sole responsibility for manufacturing and commercializing Abecma® outside the U.S.

✅ In December 2024, Roche agreed to acquire Poseida Therapeutics for up to $1.5 billion, expanding its cell therapy capabilities, particularly in developing CAR-T cell therapies for hematological malignancies.

Key Players:

=> Novartis AG, Gilead Sciences, Inc., Bristol Myers Squibb Company, Johnson & Johnson, Autolus Therapeutics, Pfizer Inc., BioNTech SE., Merck KGaA, Allogene Therapeutics, Atara Biotherapeutics, Inc. and among others.

Emerging Players:

=> AstraZeneca, Eli Lilly and Company, JW Therapeutics, and among others.

Growth Forecast Projected:

The Global Aerial Imaging Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Aerial Imaging Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=car-t-cell-therapy-market

Key Segments:

➥ By Therapy Type: Autologous CAR-T Cell Therapy, Allogeneic CAR-T Cell Therapy

➥ By Drug Type: Abecma, Breyanzi, Carvykti, Tecartus, Kymriah, Yescarta

➥ By Target Antigen: CD19, BCMA (B-cell maturation antigen), CD20, CD22, CD30, CD33, GD2, HER2, Others

➥ By Application: Acute Lymphoblastic Leukemia (ALL), Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma, Others

Regional Analysis for Aerial Imaging Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Aerial Imaging producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Aerial Imaging revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/car-t-cell-therapy-market?sb

FAQ

What is the current size of the Aerial Imaging Market?

A: In 2024, the Aerial Imaging Market was valued at US$ 4.8 billion, reflecting its strong industry presence.

Q2: How large is the Aerial Imaging Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Aerial Imaging Market will grow to around US$ 20.4 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Aerial Imaging Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 16.3% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.